Mood Disorders Flashcards: Study Guide

Q: What's the difference between Major Depressive Disorder and Persistent Depressive Disorder?

Major Depressive Disorder (MDD) requires five or more symptoms lasting at least two weeks, with significant functional impairment. Persistent Depressive Disorder (Dysthymia) involves fewer symptoms but much longer duration, at least two years in adults, creating chronic lower-grade depression. An individual with dysthymia might experience depressed mood, low energy, and concentration difficulties consistently but not severely enough to meet MDD criteria. However, a person can experience both simultaneously. A major depressive episode superimposed on dysthymia creates "double depression," where MDD symptoms temporarily worsen the chronic depressive state. The distinction matters clinically because dysthymia often requires longer-term treatment and may respond differently to medication than acute MDD episodes.

Q: Why is lithium still used despite side effects, and how does it work?

Lithium remains the gold-standard mood stabilizer because decades of research demonstrate its unique efficacy in preventing both manic and depressive episodes in bipolar disorder. It is the only medication with strong evidence for reducing suicide risk. Lithium works through multiple pathways: it inhibits inositol monophosphatase in the phosphoinositol cycle, affects protein kinase C signaling, enhances neuroprotection, and influences neurotransmitter systems. Unlike newer alternatives, lithium has extensive long-term safety and efficacy data. However, it requires careful monitoring because therapeutic and toxic levels are close. Blood levels must be checked regularly, and kidney and thyroid function need monitoring since lithium can cause hypothyroidism and nephrogenic diabetes insipidus. Patients must maintain consistent sodium and fluid intake since dehydration concentrates lithium dangerously. Despite these demands, many individuals experience superior mood stability with lithium compared to alternatives, making it invaluable for treatment-resistant cases.

Q: Can antidepressants alone treat Bipolar II Disorder, or is a mood stabilizer always necessary?

Antidepressants monotherapy for Bipolar II is generally contraindicated and can be problematic. While hypomanic episodes in Bipolar II are less severe than manic episodes in Bipolar I, antidepressants alone risk destabilizing mood and increasing cycling frequency. Current treatment guidelines recommend pairing antidepressants with mood stabilizers or atypical antipsychotics in Bipolar II. Lamotrigine shows particular efficacy for bipolar depression specifically. Some clinicians might cautiously trial an antidepressant with a mood stabilizer for depressive phases, then taper it during maintenance, but monotherapy is considered inadequate. This distinction between treating unipolar versus bipolar depression differently is crucial for clinical practice and frequently tested on exams. Bipolar depression requires mood stabilization to prevent episode cycling.

Q: What's the relationship between sleep disruption and mood episodes?

Sleep has a bidirectional relationship with mood disorders. Disrupted sleep can trigger mood episodes, and mood episodes inherently disrupt sleep. In manic episodes, people experience dramatically decreased need for sleep, feeling rested after only two or three hours. This is not insomnia (wanting sleep but unable to achieve it) but genuine decreased need, which is a hallmark diagnostic feature. In depression, sleep architecture becomes severely disrupted with early morning awakening, hypersomnia, or fragmented sleep. The circadian rhythm dysregulation underlying bipolar disorder suggests that stabilizing sleep-wake cycles forms a cornerstone of treatment. Sleep hygiene, consistent schedules, and light exposure all matter significantly. Interpersonal and Social Rhythm Therapy specifically targets this by helping patients maintain regular sleep schedules, eating times, and social activities. Recognizing sleep disruption as both symptom and trigger helps clinicians and patients understand that protecting sleep quality is a fundamental maintenance strategy.

By FluentFlash Research Team·Updated 2026-04-30

Mood disorders affect millions worldwide and represent a core topic for psychology students and healthcare professionals. These conditions include major depressive disorder, bipolar disorder, persistent depressive disorder, and cyclothymia, each with distinct diagnostic criteria and treatment needs.

Flashcards excel at teaching mood disorders because they require you to recall specific diagnostic criteria and distinguish between similar conditions. You'll memorize key symptoms, treatment approaches, and clinical reasoning all at once.

This study method leverages spaced repetition and active recall, two scientifically-proven learning techniques that strengthen memory. Organizing complex information into bite-sized questions creates a comprehensive system that prepares you for exams and real-world clinical work.

Key Takeaways

•Mood disorders are diagnosed using specific DSM-5-TR criteria requiring particular numbers of symptoms, durations, and functional impairment levels, making exact thresholds essential for accurate diagnosis
•Major depressive, bipolar I, bipolar II, and persistent depressive disorders have distinct presentations requiring different treatment approaches, making differential diagnosis critical for clinical success
•Biological mechanisms including neurotransmitter dysregulation, HPA axis dysfunction, and genetic vulnerability interact with psychological factors like cognitive patterns and life stressors to create mood disorders
•Treatment combines pharmacotherapy (SSRIs for unipolar depression, mood stabilizers like lithium for bipolar disorder) with psychotherapy (CBT, IPSRT) and lifestyle modifications based on disorder type
•Antidepressants alone can harm bipolar disorder without concurrent mood stabilizers, making the distinction between unipolar and bipolar depression clinically crucial
•Flashcards enhance learning through spaced repetition, active recall, and forced conceptual clarity, proving particularly valuable for mastering symptom lists, diagnostic thresholds, and differential diagnosis distinctions

Understanding the Major Types of Mood Disorders

Mood disorders involve persistent disturbances in emotional regulation that significantly impact daily functioning. The major categories include depressive disorders, bipolar and related disorders, and other specified mood disorders.

Major Depressive Disorder (MDD)

MDD requires at least two weeks of depressed mood or anhedonia (loss of pleasure). Additional symptoms include appetite changes, sleep disturbance, fatigue, difficulty concentrating, and suicidal thoughts. The condition must cause significant functional impairment.

Persistent Depressive Disorder (Dysthymia)

Dysthymia involves milder symptoms lasting at least two years in adults. The symptoms are less severe but much longer-lasting than MDD. Individuals with dysthymia often experience low energy and reduced concentration persistently.

Bipolar Disorders and Cyclothymia

Bipolar I Disorder requires at least one manic episode with elevated mood, decreased sleep need, racing thoughts, and increased goal-directed activity. Bipolar II Disorder involves hypomanic episodes (less severe) alternating with depressive episodes. Cyclothymia presents as chronic mood instability with hypomanic and depressive symptoms that don't meet full bipolar criteria.

Understanding these distinctions is crucial because misdiagnosis leads to inappropriate treatment. For example, treating bipolar disorder with antidepressants alone can trigger mood episodes. Flashcards help you internalize specific duration requirements, symptom thresholds, and distinguishing features that separate these diagnoses.

Diagnostic Criteria and Classification Systems

The DSM-5-TR provides standardized diagnostic criteria for mood disorders used throughout North America. These criteria are precise and require careful application during assessment.

DSM-5-TR Criteria for Major Depressive Disorder

MDD requires five or more symptoms present during the same two-week period. At least one must be depressed mood or loss of interest/pleasure. The nine possible symptoms include:

Depressed mood
Anhedonia (loss of pleasure)
Significant weight or appetite change
Insomnia or hypersomnia
Psychomotor agitation or retardation
Fatigue or loss of energy
Worthlessness or guilt
Diminished concentration
Recurrent thoughts of death

Symptoms must cause clinically significant distress or functional impairment and cannot be attributable to substance use or another medical condition.

Bipolar I and Classification Systems

Bipolar I Disorder requires a single manic episode lasting at least seven days. The ICD-11 offers an alternative classification system used internationally with slightly different organizational structures but similar core concepts.

Mastering these criteria requires more than memorization. You must distinguish between symptoms and disorders, understand time thresholds, and recognize how cultural factors may present differently. Scenario-based flashcards help you apply criteria: given a patient presentation, can you identify which symptoms are present, count them, assess duration, and determine if diagnostic criteria are met?

Etiology, Risk Factors, and Biological Mechanisms

Mood disorders result from complex interactions between biological, psychological, and social factors. Understanding these mechanisms helps explain why certain treatments work effectively.

Neurochemical and Brain Structure Factors

The biogenic amine hypothesis suggests depression results from insufficient levels of serotonin, norepinephrine, and dopamine in key brain regions. Neuroimaging reveals structural abnormalities including reduced hippocampus and prefrontal cortex volume, and hyperactivity in the amygdala.

The hypothalamic-pituitary-adrenal (HPA) axis regulates stress response through cortisol production. Dysregulation in depressed individuals causes elevated cortisol levels that interfere with normal brain function.

Genetic and Environmental Contributions

Genetic factors contribute significantly. First-degree relatives of individuals with mood disorders show substantially higher risk. Environmental triggers are equally important, including life stressors, trauma, loss, social isolation, and chronic medical conditions.

Cognitive and Circadian Factors

Cognitive theories emphasize negative thinking patterns, learned helplessness, and rumination as maintaining factors in depression. For bipolar disorder, dysregulation affects multiple systems including circadian rhythms and sleep-wake cycles.

Connecting symptoms to underlying mechanisms creates a coherent framework rather than isolated facts, which deepens comprehension and retention substantially.

Treatment Approaches and Psychopharmacology

Mood disorder treatment typically combines pharmacological and psychosocial interventions tailored to the specific disorder type and individual factors.

Antidepressants for Unipolar Depression

Antidepressants are first-line medications for unipolar depression. Classes include SSRIs (selective serotonin reuptake inhibitors) like sertraline and paroxetine, SNRIs (serotonin-norepinephrine reuptake inhibitors) like venlafaxine, tricyclic antidepressants, and MAOIs. SSRIs are preferred initially due to better tolerability and safety profiles, though response rates hover around 60-70%. Many patients require trials of multiple medications.

Mood Stabilizers for Bipolar Disorder

Mood stabilizers are essential for Bipolar I Disorder to prevent manic episodes. Lithium remains gold-standard but requires blood level monitoring and kidney/thyroid function checks. Anticonvulsants like valproate and lamotrigine serve as alternatives or adjuncts. Atypical antipsychotics including quetiapine and lurasidone treat acute mania and maintain stability.

A critical principle: using antidepressants alone in bipolar disorder without a mood stabilizer risks triggering manic or hypomanic episodes.

Psychotherapy and Lifestyle Approaches

Cognitive-Behavioral Therapy (CBT) addresses negative thought patterns and behavioral activation. Interpersonal and Social Rhythm Therapy (IPSRT) stabilizes circadian rhythms. Lifestyle modifications including sleep regulation, exercise, social engagement, and substance avoidance significantly enhance outcomes.

Severe cases may require electroconvulsive therapy (ECT) or transcranial magnetic stimulation (TMS). Flashcards help you memorize medication classes, side effects, and appropriate treatment contexts while developing clinical reasoning.

Why Flashcards Are Optimal for Learning Mood Disorders

Mood disorders involve extensive factual content that seems overwhelming without systematic study. Flashcards transform this challenge through several scientific mechanisms.

Spaced Repetition and Active Recall

Spaced repetition scientifically optimizes memory formation through algorithms that present difficult cards more frequently. You gradually increase intervals for mastered content, ensuring long-term retention with minimum study time. Active recall (retrieving information from memory) strengthens neural pathways and prepares you for exam conditions where you must generate answers.

Conceptual Clarity and Discriminative Learning

Flashcards force conceptual clarity because writing quality questions requires deep understanding. Poorly-constructed cards reveal gaps in comprehension immediately. They facilitate discriminative learning crucial for mood disorders. Side-by-side cards comparing depressive versus manic symptoms, or Bipolar I versus Bipolar II criteria, directly address challenging differential diagnoses appearing on exams.

Cumulative and Scenario-Based Learning

Flashcards support cumulative learning by integrating information from lectures, textbooks, and practice questions into one coherent system. You can self-test under exam-like conditions, reducing test anxiety and building confidence.

For mood disorders specifically, effective flashcards move beyond pure memorization. Include scenario-based questions (given symptoms, identify the disorder), mechanism questions (why does this drug treat this condition), and integration questions (how do biological and psychological factors interact). This comprehensive approach yields higher exam scores and deeper clinical understanding.

Start Studying Mood Disorders

Master diagnostic criteria, symptoms, and treatment approaches with scientifically-designed flashcards that use spaced repetition to ensure lasting retention. Build clinical competence while acing your exams.

Create Free Flashcards

Frequently Asked Questions

What's the difference between Major Depressive Disorder and Persistent Depressive Disorder?

Major Depressive Disorder (MDD) requires five or more symptoms lasting at least two weeks, with significant functional impairment. Persistent Depressive Disorder (Dysthymia) involves fewer symptoms but much longer duration, at least two years in adults, creating chronic lower-grade depression.

An individual with dysthymia might experience depressed mood, low energy, and concentration difficulties consistently but not severely enough to meet MDD criteria. However, a person can experience both simultaneously. A major depressive episode superimposed on dysthymia creates "double depression," where MDD symptoms temporarily worsen the chronic depressive state.

The distinction matters clinically because dysthymia often requires longer-term treatment and may respond differently to medication than acute MDD episodes.

Why is lithium still used despite side effects, and how does it work?

Lithium remains the gold-standard mood stabilizer because decades of research demonstrate its unique efficacy in preventing both manic and depressive episodes in bipolar disorder. It is the only medication with strong evidence for reducing suicide risk.

Lithium works through multiple pathways: it inhibits inositol monophosphatase in the phosphoinositol cycle, affects protein kinase C signaling, enhances neuroprotection, and influences neurotransmitter systems. Unlike newer alternatives, lithium has extensive long-term safety and efficacy data.

However, it requires careful monitoring because therapeutic and toxic levels are close. Blood levels must be checked regularly, and kidney and thyroid function need monitoring since lithium can cause hypothyroidism and nephrogenic diabetes insipidus. Patients must maintain consistent sodium and fluid intake since dehydration concentrates lithium dangerously.

Despite these demands, many individuals experience superior mood stability with lithium compared to alternatives, making it invaluable for treatment-resistant cases.

Can antidepressants alone treat Bipolar II Disorder, or is a mood stabilizer always necessary?

Antidepressants monotherapy for Bipolar II is generally contraindicated and can be problematic. While hypomanic episodes in Bipolar II are less severe than manic episodes in Bipolar I, antidepressants alone risk destabilizing mood and increasing cycling frequency.

Current treatment guidelines recommend pairing antidepressants with mood stabilizers or atypical antipsychotics in Bipolar II. Lamotrigine shows particular efficacy for bipolar depression specifically. Some clinicians might cautiously trial an antidepressant with a mood stabilizer for depressive phases, then taper it during maintenance, but monotherapy is considered inadequate.

This distinction between treating unipolar versus bipolar depression differently is crucial for clinical practice and frequently tested on exams. Bipolar depression requires mood stabilization to prevent episode cycling.

What's the relationship between sleep disruption and mood episodes?

Sleep has a bidirectional relationship with mood disorders. Disrupted sleep can trigger mood episodes, and mood episodes inherently disrupt sleep.

In manic episodes, people experience dramatically decreased need for sleep, feeling rested after only two or three hours. This is not insomnia (wanting sleep but unable to achieve it) but genuine decreased need, which is a hallmark diagnostic feature. In depression, sleep architecture becomes severely disrupted with early morning awakening, hypersomnia, or fragmented sleep.

The circadian rhythm dysregulation underlying bipolar disorder suggests that stabilizing sleep-wake cycles forms a cornerstone of treatment. Sleep hygiene, consistent schedules, and light exposure all matter significantly. Interpersonal and Social Rhythm Therapy specifically targets this by helping patients maintain regular sleep schedules, eating times, and social activities.

Recognizing sleep disruption as both symptom and trigger helps clinicians and patients understand that protecting sleep quality is a fundamental maintenance strategy.

How do I distinguish between normal sadness and clinical depression on exams?

This frequently-tested distinction hinges on several key factors. Normal sadness is proportional to triggering events, temporary, and does not substantially impair functioning. A person might feel sad about losing a job but still manage basic self-care, work toward solutions, and gradually feel better.

Clinical depression involves depressed mood or anhedonia that is either unexplained by external events or far exceeds what circumstances warrant. It persists for at least two weeks, involves multiple symptoms simultaneously (sleep changes, appetite changes, fatigue, guilt, concentration problems, suicidal ideation), and significantly impairs functioning in work, school, relationships, or self-care.

Grief following loss deserves special mention because it can look depression-like but typically involves preserved interest in certain activities. It does not constitute MDD unless it meets full criteria and persists beyond expected timeframes.

Exam questions often present scenarios requiring you to identify whether symptoms constitute clinical disorder or normal emotional responses. The key is recognizing that diagnosis requires multiple criteria, functional impairment, and appropriate duration, not mood symptoms alone.